公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2012 | Loss of 18q22.3 involving the carboxypeptidase of glutamate-like gene is associated with poor prognosis in resected pancreatic cancer | JIH-HSIANG LEE ; Giovannetti E.; Hwang J.-H.; Petrini I.; Wang Q.; Voortman J.; Wang Y.; Steinberg S.M.; Funel N.; Meltzer P.S.; Wang Y.; Giaccone G. | Clinical Cancer Research | 22 | 20 | |
2013 | MEK inhibitors reverse resistance in epidermal growth factor receptor mutation lung cancer cells with acquired resistance to gefitinib | Huang M.-H.; JIH-HSIANG LEE ; Chang Y.-J.; Tsai H.-H.; Lin Y.-L.; Lin A.M.Y.; CHIH-HSIN YANG | Molecular Oncology | 71 | 63 | |
2011 | MicroRNA expression and clinical outcome of small cell lung cancer | JIH-HSIANG LEE ; Voortman J.; Dingemans A.-M.C.; Voeller D.M.; Pham T.; Wang Y.; Giaccone G. | PLoS ONE | 68 | 53 | |
2009 | Multifocal primary cutaneous CD30+ anaplastic large cell lymphoma responsive to thalidomide: The molecular mechanism and the clinical application | JIH-HSIANG LEE ; ANN-LII CHENG ; CHUNG-WU LIN ; SUNG-HSIN KUO | British Journal of Dermatology | 12 | 9 | |
2017 | New data on clinical decisions in NSCLC patients with uncommon EGFR mutations | Wu T.; Hsiue E.H.; JIH-HSIANG LEE ; Chia-Chi Lin ; CHIH-HSIN YANG | Expert Review of Respiratory Medicine | 15 | 14 | |
2024 | A novel computer-assisted tool for 3D imaging of programmed death-ligand 1 expression in immunofluorescence-stained and optically cleared breast cancer specimens | Lee, Yi-Hsuan; Huang, Chung-Yen; Hsieh, Yu-Han; Yang, Chia-Hung; Hung, Yu-Ling; Chen, Yung-An; Lin, Yu-Chieh; Lin, Ching-Hung; JIH-HSIANG LEE ; Wang, Ming-Yang; Kuo, Wen-Hung; Lin, Yen-Yin; YEN-SHEN LU | BMC cancer | | | |
2017 | Optimal management of EGFR-mutant non-small cell lung cancer with disease progression on first-line tyrosine kinase inhibitor therapy | BIN-CHI LIAO ; Chia-Chi Lin ; JIH-HSIANG LEE ; CHIH-HSIN YANG | Lung Cancer | 38 | 35 | |
2018 | Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study | CHIA-CHI LIN ; JIN-YUAN SHIH ; CHONG-JEN YU ; CHAO-CHI HO ; WEI-YU LIAO ; JIH-HSIANG LEE ; TZU-HSIU TSAI ; KANG-YI SU ; MIN-SHU HSIEH ; YIH-LEONG CHANG ; Bai Y.-Y.; DE-RUI HUANG ; Thress K.S.; CHIH-HSIN YANG | The Lancet Respiratory Medicine | 120 | 109 | |
2018 | Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors | BIN-CHI LIAO ; Bai Y.-Y; JIH-HSIANG LEE ; CHIA-CHI LIN ; SHU-YUNG LIN ; YEE-FAN LEE ; CHAO-CHI HO ; JIN-YUAN SHIH ; YEUN-CHUNG CHANG ; CHONG-JEN YU ; CHIH-HSIN YANG ; PAN-CHYR YANG | Journal of the Formosan Medical Association | 11 | 9 | |
2010 | Pemetrexed for heavily pretreated patients with advanced non-small cell lung cancer | JIH-HSIANG LEE ; CHONG-JEN YU ; KUAN-YU CHEN ; JIN-YUAN SHIH ; Lin Y.-L.; CHIH-HSIN YANG | Journal of the Formosan Medical Association | 6 | 5 | |
2020 | A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors | JIH-HSIANG LEE ; WEI-WU CHEN ; CHIH-HUNG HSU ; Yen Y.-H.; CHIH-HSIN YANG ; ANN-LII CHENG ; Sasaki S.-I.; Chiu L.Y.; Sugihara M.; Ishizuka T.; Oguma T.; Tajima N.; CHIA-CHI LIN | Investigational New Drugs | 39 | 36 | |
2022 | Potential Therapeutic Strategy for EGFR-Mutant Lung Cancer With Concomitant EML4-ALK Rearrangement-Combination of EGFR Tyrosine Kinase Inhibitors and ALK Inhibitors | Huang, Ming-Hung; JIH-HSIANG LEE ; Hung, Pei-Shan; Chih-Hsin Yang, James | JTO clinical and research reports | 2 | 0 | |
2016 | Profile of the therascreen® EGFR RGQ PCR kit as a companion diagnostic for gefitinib in non-small cell lung cancer | Hsiue E.H.-C; JIH-HSIANG LEE ; CHIA-CHI LIN ; CHIH-HSIN YANG | Expert Review of Molecular Diagnostics | 15 | 14 | |
2022 | Real-world treatment patterns and outcomes among patients with advanced non-small-cell lung cancer with spindle cell and/or giant cell carcinoma | CHIA-LING CHANG ; MIN-SHU HSIEH ; JIN-YUAN SHIH ; Lee, Yi-Hsuan; WEI-YU LIAO ; CHIA-LIN HSU ; CHING-YAO YANG ; KUAN-YU CHEN ; JIH-HSIANG LEE ; CHAO-CHI HO ; TZU-HSIU TSAI ; CHIH-HSIN YANG ; CHONG-JEN YU | Therapeutic advances in medical oncology | 1 | 1 | |
2023 | Recommended first-line management of asymptomatic brain metastases from EGFR mutant and ALK positive non-small cell lung cancer varies significantly according to specialty: an international survey of clinical practice | Fong, Chin Heng; Meti, Nicholas; Kruser, Timothy; Weiss, Jessica; Liu, Zhihui Amy; Takami, Hirokazu; Narita, Yoshitaka; de Moraes, Fabio Ynoe; Dasgupta, Archya; Ong, Choo Khoon; CHIH-HSIN YANG ; JIH-HSIANG LEE ; Kosyak, Natalya; Pavlakis, Nicholas; Kongkham, Paul; Doherty, Mark; Leighl, Natasha B; Shultz, David B | Journal of thoracic disease | 3 | 3 | |
2022 | Recommended first-line management of brain metastases from melanoma: A multicenter survey of clinical practice | Jablonska, Paola Anna; Fong, Chin Heng; Kruser, Timothy; Weiss, Jessica; Liu, Zhihui Amy; Takami, Hirokazu; Narita, Yoshitaka; Ynoe de Moraes, Fabio; Dasgupta, Archya; Ong, Choo Khoon; CHIH-HSIN YANG ; JIH-HSIANG LEE ; Pavlakis, Nicholas; Kongkham, Paul; Butler, Marcus; Shultz, David B | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology | 2 | 2 | |
2014 | Role of CYB5A in pancreatic cancer prognosis and autophagy modulation | Giovannetti E.; Wang Q.; Avan A.; Funel N.; Lagerweij T.; JIH-HSIANG LEE ; Caretti V.; Van Der Velde A.; Boggi U.; Wang Y.; Vasile E.; Peters G.J.; Wurdinger T.; Giaccone G. | Journal of the National Cancer Institute | 57 | 49 | |
2016 | Safety of gefitinib in non-small cell lung cancer treatment | Hsiue E.H.-C.; JIH-HSIANG LEE ; CHIA-CHI LIN ; CHIH-HSIN YANG | Expert Opinion on Drug Safety | 19 | 15 | |
2021 | Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M–Positive NSCLC | BIN-CHI LIAO ; Hsu, Wei-Hsun; JIH-HSIANG LEE ; CHING-YAO YANG ; TZU-HSIU TSAI ; WEI-YU LIAO ; CHAO-CHI HO ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHONG-JEN YU ; Soo, Ross A; CHIH-HSIN YANG | JTO clinical and research reports | 2 | 0 | |
2017 | A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancer | Soh S.X.; Siddiqui F.J.; Allen J.C.; Kim G.W.; Lee J.C.; Yatabe Y.; Soda M.; Mano H.; Soo R.A.; Chin T.-M.; Ebi H.; Yano S.; Matsuo K.; Niu X.; Lu S.; Isobe K.; JIH-HSIANG LEE ; CHIH-HSIN YANG ; Zhao M.; Zhou C.; Lee J.-K.; Lee S.-H.; Lee J.Y.; Ahn M.-J.; Tan T.J.; Tan D.S.; Tan E.-H.; Ong S.T.; Lim W.-T. | Oncotarget | 14 | 12 | |